A detailed history of Arden Trust CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Arden Trust CO holds 12,175 shares of NVO stock, worth $1.28 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
12,175
Previous 13,076 6.89%
Holding current value
$1.28 Million
Previous $1.68 Million 3.52%
% of portfolio
0.25%
Previous 0.25%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

SELL
$122.71 - $146.91 $110,561 - $132,365
-901 Reduced 6.89%
12,175 $1.74 Million
Q1 2024

Apr 03, 2024

SELL
$102.11 - $135.92 $52,382 - $69,726
-513 Reduced 3.78%
13,076 $1.68 Million
Q4 2023

Jan 04, 2024

SELL
$87.78 - $105.45 $195,486 - $234,837
-2,227 Reduced 14.08%
13,589 $1.41 Million
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $573,558 - $1.26 Million
6,307 Added 66.33%
15,816 $1.44 Million
Q2 2023

Jul 14, 2023

SELL
$155.98 - $172.65 $86,568 - $95,820
-555 Reduced 5.51%
9,509 $1.54 Million
Q1 2023

Apr 14, 2023

BUY
$132.34 - $159.14 $47,245 - $56,812
357 Added 3.68%
10,064 $1.6 Million
Q4 2022

Jan 20, 2023

BUY
$102.55 - $135.33 $85,834 - $113,271
837 Added 9.44%
9,707 $0
Q3 2022

Oct 20, 2022

BUY
$95.28 - $116.93 $102,521 - $125,816
1,076 Added 13.81%
8,870 $883,000
Q2 2022

Jul 12, 2022

SELL
$103.24 - $121.81 $307,242 - $362,506
-2,976 Reduced 27.63%
7,794 $869,000
Q1 2022

Apr 11, 2022

SELL
$93.1 - $112.54 $13,034 - $15,755
-140 Reduced 1.28%
10,770 $1.2 Million
Q4 2021

Jan 24, 2022

SELL
$95.88 - $117.08 $11,697 - $14,283
-122 Reduced 1.11%
10,910 $1.22 Million
Q3 2021

Oct 12, 2021

SELL
$84.42 - $106.62 $115,739 - $146,176
-1,371 Reduced 11.05%
11,032 $1.06 Million
Q2 2021

Jul 19, 2021

SELL
$67.66 - $84.76 $74,223 - $92,981
-1,097 Reduced 8.13%
12,403 $1.04 Million
Q1 2021

Apr 23, 2021

BUY
$67.06 - $75.82 $71,016 - $80,293
1,059 Added 8.51%
13,500 $910,000
Q4 2020

Jan 15, 2021

SELL
$63.89 - $73.8 $7,858 - $9,077
-123 Reduced 0.98%
12,441 $869,000
Q3 2020

Oct 15, 2020

BUY
$63.69 - $70.22 $93,433 - $103,012
1,467 Added 13.22%
12,564 $872,000
Q2 2020

Jul 09, 2020

SELL
$58.54 - $67.94 $51,749 - $60,058
-884 Reduced 7.38%
11,097 $726,000
Q1 2020

Apr 16, 2020

SELL
$49.46 - $64.78 $13,552 - $17,749
-274 Reduced 2.24%
11,981 $721,000
Q4 2019

Jan 17, 2020

SELL
$49.86 - $58.26 $15,855 - $18,526
-318 Reduced 2.53%
12,255 $709,000
Q2 2019

Jul 23, 2019

BUY
$46.79 - $52.47 $588,290 - $659,705
12,573 New
12,573 $642,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Arden Trust CO Portfolio

Follow Arden Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Arden Trust CO with notifications on news.